Remove 2007 Remove FDA Remove Hospitals
article thumbnail

Trial of Jazz’ cannabis drug in glioblastoma will start next year

pharmaphorum

The Leeds investigators aim to recruit more than 230 patients with glioblastoma at 15 NHS hospitals in the UK from March 2022, who will be treated after evidence of first disease progression following first-line radiotherapy and chemotherapy with Merck & Co/MSD’s Temodal (temozolomide).

article thumbnail

Vyvanse generic availability, cost, and dosage

The Checkup by Singlecare

Food and Drug Administration (FDA) in 2007 for treatment and symptom control in ADHD. In 2015, Vyvanse was approved by the FDA also to treat binge eating disorder ( BED ). Generally speaking, the FDA approval process ensures no significant difference between brand and generic drugs.

Dosage 92
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical decision-making insights for haematologists and oncologists

pharmaphorum

Professor Mohamad Mohty, head of haematology and cellular therapy at Saint-Antoine Hospital, told the webinar audience: “It is really amazing to see the number of haematology indications, whether for new molecular entities or for biosimilars.”. for the period from 2007-2013.

FDA 105
article thumbnail

Next Generation Complement Therapeutics: Potential Life-Changing Therapies for Multiple Rare Disorders

Roots Analysis

Since the approval of Soliris® in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. Some of the complement therapeutics, namely Berinert®, Cinryze®, ORLADEYO®, Ruconest® and TAKHZYRO® were approved for the treatment of hereditary angioedema, by the US FDA and the EMA.

article thumbnail

Drug development and working with specialised Rare Disease networks

pharmaphorum

However, despite the work still left to be done, there are now a growing number of treatments in the pipeline and 2020 proved to be a remarkable year for orphan drug approvals, with the US FDA approving more orphan designated treatments than non-orphan drugs.

article thumbnail

Propranolol interactions to avoid

The Checkup by Singlecare

Sources: Innopran XL prescribing information , FDA Possible interactions with calcium , St. By staying proactive and vigilant about potential propranolol interactions, you can ensure the best possible outcomes for your health.

Dosage 52
article thumbnail

Why Are FDA Inspections So Ineffective and Disappointing?

The People's Pharmacy

Why, then, are FDA inspections abroad so infrequent and disappointing? FDA Inspections Suspended: During the COVID pandemic, the Food and Drug Administration suspended its inspections at most foreign pharmaceutical facilities. Even under the best of conditions, the FDA never inspects all foreign pharmaceutical plants annually.

FDA 72